Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
253
-
Total 13F shares, excl. options
-
43.1M
-
Shares change
-
-730K
-
Total reported value, excl. options
-
$859M
-
Value change
-
-$17.7M
-
Put/Call ratio
-
0.91
-
Number of buys
-
86
-
Number of sells
-
-133
-
Price
-
$19.91
Significant Holders of AVANOS MEDICAL, INC. - Common Stock (AVNS) as of Q1 2024
294 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock as of Q1 2024.
AVANOS MEDICAL, INC. - Common Stock (AVNS) has 253 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.1M shares
of 46.1M outstanding shares and own 93.49% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.26M shares), VANGUARD GROUP INC (5.4M shares), RGM Capital, LLC (3.17M shares), DIMENSIONAL FUND ADVISORS LP (2.68M shares), WESTWOOD HOLDINGS GROUP INC (2.11M shares), STATE STREET CORP (1.98M shares), T. Rowe Price Investment Management, Inc. (1.93M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.43M shares), BROWN ADVISORY INC (1.4M shares), and Paradice Investment Management LLC (1.28M shares).
This table shows the top 253 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.